Description
ADU-S100 sodium salt is a synthetic cyclic dinucleotide agonist of STING.
| Product Unit Size | Cost | Quantity | Stock |
|---|
ADU-S100 sodium salt is a synthetic cyclic dinucleotide agonist of STING.
| Cas No. | 1638750-95-4 |
|---|---|
| Purity | ≥99% |
| Formula | C20H22N10O10P2S2 • 2Na |
| Formula Wt. | 734.5 |
| IUPAC Name | Disodium;(1R,6R,8R,9R,10S,15R,17R)-8,17-bis(6-aminopurin-9-yl)-3,12-dihydroxy-3,12-bis(sulfanylidene)-2,4,7,11,13,16-hexaoxa-3λ5,12λ5-diphosphatricyclo[13.2.1.06,10]octadecane-9,18-diol |
| Synonym | ML RR-S2 CDA Sodium Salt; STING-Inducer-1; MIW815; GTPL10192; Dithio-(Rp,Rp)-[cyclic[A(2',5')pA(3',5')p]]Â Â Â |
| Solubility | Soluble in water (>36.7 mg/mL, >50 mM) |
| Appearance | White crystalline powder |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| MSDS | |
|---|---|
| Info Sheet |
Sivick KE, Desbien AL, Glickman LH, et al. Magnitude of therapeutic STING activation determines CD8+ cell-mediated anti-tumor immunity. Cell Rep. 2018 Dec 11;25(11):3074-3085. PMID: 30540940.
Peptide, IgG derivative, tuftsin analog.
Bone deterioration inhibitor, potential CaR ago...
PKA inhibitor.
Synthetic peptide, vasopressin analog; AVPR1 ag...
Endogenous peptide hormone; CCK2 agonist, indir...
Respiratory toxin, mitochondrial permeability t...
5-HT2 antagonist, SERT and NET inhibitor, hERG ...
Polypeptide antibiotic produced from Streptomyc...
FGFR inhibitor.
Coumarin, more potent isomer; VKORC1 inhibitor....
Neuraminidase inhibitor.
Endogenous neurotransmitter; GABA agonist.
Triterpene saponin found in species of Panax; Î...
Protonophore; chitinase OvCHT1 inhibitor.
Synthetic ITC.
Alters intracellular glutathione levels.
Endogenous thyroid hormone T4.
Trichothecene mycotoxin produced by Fusarium.
Histamine H2 inverse agonist.
Polyphenolic hydroxystilbene, resveratrol deri...